Prostate-specific antigen based screening results in small or no reduction in prostate cancer specific mortality and is associated with harms related to subsequent evaluation and treatments,
some of which may be unnecessary.
[swfobj src=”https://medicinainternaelsalvador.com/wp-content/uploads/2012/03/prostata1.swf” width=”700″ height=”500″ align=”center” allowfullscreen=”true”]